Ahead of the publication on Friday 30 January of a paper in The Lancet Neurology reporting the results of a trial involving stem cell transplantation in people with relapsing remitting multiple sclerosis (MS), please find below a comment from the MS Society: Dr Doug Brown,
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.